Abstract | UNLABELLED: CONCLUSION: In contrast to what is often stated, erythema nodosum is not always a benign condition. On the basis of this report, we suggest that if extensive erythema nodosum develops in an individual without any known thrombophilic disorder, investigations with respect to the latter should be performed.
|
Authors | Cathrine Foyn Bruun, Bodil Langbakk, Sonja Eriksson Steigen |
Journal | Acta paediatrica (Oslo, Norway : 1992)
(Acta Paediatr)
Vol. 94
Issue 8
Pg. 1155-8
(Aug 2005)
ISSN: 0803-5253 [Print] Norway |
PMID | 16188867
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- factor V Leiden
- Warfarin
- Factor V
- Heparin
- Prednisolone
|
Topics |
- Biopsy, Needle
- Child
- Combined Modality Therapy
- Erythema Nodosum
(complications, diagnosis, therapy)
- Factor V
(genetics)
- Follow-Up Studies
- Heparin
(therapeutic use)
- Humans
- IgA Vasculitis
(complications, diagnosis, therapy)
- Immunohistochemistry
- Male
- Plasma Exchange
- Point Mutation
- Prednisolone
(therapeutic use)
- Protein S Deficiency
(complications, diagnosis, genetics, therapy)
- Risk Assessment
- Severity of Illness Index
- Treatment Outcome
- Warfarin
(therapeutic use)
|